BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23276469)

  • 41. HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumonia.
    Wang RJ; Moore J; Moisi D; Chang EG; Byanyima P; Kaswabuli S; Musisi E; Sanyu I; Sessolo A; Lalitha R; Worodria W; Davis JL; Crothers K; Lin J; Lederman MM; Hunt PW; Huang L
    PLoS One; 2019; 14(5):e0216680. PubMed ID: 31091258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is low-level HIV-1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease?
    Elvstam O; Medstrand P; Jansson M; Isberg PE; Gisslén M; Björkman P
    HIV Med; 2019 Oct; 20(9):571-580. PubMed ID: 31148335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors Associated With Plasma IL-6 Levels During HIV Infection.
    Borges ÁH; O'Connor JL; Phillips AN; Rönsholt FF; Pett S; Vjecha MJ; French MA; Lundgren JD;
    J Infect Dis; 2015 Aug; 212(4):585-95. PubMed ID: 25722296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies.
    Lowe GD; Sweetnam PM; Yarnell JW; Rumley A; Rumley C; Bainton D; Ben-Shlomo Y
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1957-62. PubMed ID: 15308549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12-month mortality in South Africa and Uganda.
    Siedner MJ; Bwana MB; Asiimwe S; Musinguzi N; Castillo-Mancilla J; Amanyire G; Tracy RP; Bangsberg DR; Orrell C; Haberer JE;
    AIDS; 2019 Nov; 33(13):2043-2048. PubMed ID: 31274541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda.
    Okello S; Asiimwe SB; Kanyesigye M; Muyindike WR; Boum Y; Mwebesa BB; Haberer JE; Huang Y; Williams K; Burdo TH; Tracy RP; Bangsberg DR; Mocello AR; Martin JN; Hunt PW; Siedner MJ
    J Acquir Immune Defic Syndr; 2016 Dec; 73(4):396-402. PubMed ID: 27171743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women.
    Kiefer EM; Hoover DR; Shi Q; Dusingize JC; Sinayobye JD; Anastos K
    HIV Med; 2018 Nov; 19(10):734-744. PubMed ID: 30160347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Associations between fibrin D-dimer, markers of inflammation, incident self-reported mobility limitation, and all-cause mortality in older men.
    Wannamethee SG; Whincup PH; Lennon L; Papacosta O; Lowe GD
    J Am Geriatr Soc; 2014 Dec; 62(12):2357-62. PubMed ID: 25516032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of interleukin-6 in combination with D-dimer in predicting early poor postoperative prognosis after acute stanford type a aortic dissection.
    Wu Q; Li J; Chen L; Yan LL; Qiu Z; Shen Y; Xie X; Xie L
    J Cardiothorac Surg; 2020 Jul; 15(1):172. PubMed ID: 32677975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection.
    Swaminathan S; Hu Z; Rupert AW; Higgins JM; Dewar RL; Stevens R; Chen Q; Rehm CA; Metcalf JA; Baseler MW; Lane HC; Imamichi T
    PLoS One; 2014; 9(6):e98989. PubMed ID: 24896094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection.
    Scherzer R; Shah SJ; Secemsky E; Butler J; Grunfeld C; Shlipak MG; Hsue PY
    Circ Heart Fail; 2018 Apr; 11(4):e004312. PubMed ID: 29615435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrocardiographic abnormalities among people with HIV in Shanghai, China.
    Shen F; Zhu B; Ding Y; Gao M; He N
    Biosci Trends; 2020 Mar; 14(1):9-15. PubMed ID: 32074547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.
    ;
    AIDS; 2008 Sep; 22(14):F17-24. PubMed ID: 18753925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals.
    Achhra AC; Amin J; Sabin C; Chu H; Dunn D; Kuller LH; Kovacs JA; Cooper DA; Emery S; Law MG;
    AIDS; 2012 Aug; 26(13):1707-17. PubMed ID: 22614887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.
    McDonald B; Moyo S; Gabaitiri L; Gaseitsiwe S; Bussmann H; Koethe JR; Musonda R; Makhema J; Novitsky V; Marlink RG; Wester CW; Essex M
    AIDS Res Hum Retroviruses; 2013 Jul; 29(7):993-9. PubMed ID: 23590237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.
    Baker JV; Neuhaus J; Duprez D; Cooper DA; Hoy J; Kuller L; Lampe FC; Liappis A; Friis-Moller N; Otvos J; Paton NI; Tracy R; Neaton JD;
    AIDS; 2011 Nov; 25(17):2133-42. PubMed ID: 21857489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.
    Baker J; Ayenew W; Quick H; Hullsiek KH; Tracy R; Henry K; Duprez D; Neaton JD
    J Infect Dis; 2010 Jan; 201(2):285-92. PubMed ID: 19954384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contribution of Oxidative Stress to Non-AIDS Events in HIV-Infected Patients.
    Masiá M; Padilla S; Fernández M; Barber X; Moreno S; Iribarren JA; Portilla J; Peña A; Vidal F; Gutiérrez F;
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):e36-e44. PubMed ID: 28107228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemostasis biomarkers and incident cognitive impairment: the REGARDS study.
    Gillett SR; McClure LA; Callas PW; Thacker EL; Unverzagt FW; Wadley VG; Letter AJ; Cushman M
    J Thromb Haemost; 2018 Jul; 16(7):1259-1267. PubMed ID: 29733497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.
    Kaplan RC; Landay AL; Hodis HN; Gange SJ; Norris PJ; Young M; Anastos K; Tien PC; Xue X; Lazar J; Parrinello CM; Benning L; Tracy RP
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):359-68. PubMed ID: 22592585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.